Effect of Hepatitis C Virus Treatment on Rejection Incidence and Severity in post-liver transplant Recepients
Zeinab Mohamed Nabil Mohamed;
Abstract
D
AAs are promising drugs in treatment of HCV infection in liver transplant recipients. Pegylated INF therapy was claimed to increase risk of graft rejection in such patients. However, the risk of rejection with DAAs is not well addressed.
In this study, we compared recipients of liver transplant who were infected with HCV as regard risk of rejection with different regimens of antiviral.
AAs are promising drugs in treatment of HCV infection in liver transplant recipients. Pegylated INF therapy was claimed to increase risk of graft rejection in such patients. However, the risk of rejection with DAAs is not well addressed.
In this study, we compared recipients of liver transplant who were infected with HCV as regard risk of rejection with different regimens of antiviral.
Other data
| Title | Effect of Hepatitis C Virus Treatment on Rejection Incidence and Severity in post-liver transplant Recepients | Other Titles | تأثير علاج الفيروس الكبدي سي على احتمالية حدوث وشدة الرفض في المرضى بعد زرع الكبد | Authors | Zeinab Mohamed Nabil Mohamed | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.